today announced that its Board of Directors (the “Board”) has approved a 1-for-20 reverse stock split (“Reverse Split”) of its Class A common stock, Class B common stock and Class C common stock
LadRx Corporation today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 100 pre-split shares.
electroCore, Inc., a commercial-stage bioelectronic medicine and wellness company, announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-15. ROCKAWAY, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) --electroCore, Inc.(Nasdaq: ECOR) (the “Company”), a...
Rigel Pharmaceuticals () on Tuesday announced a reverse stock split, where every 10 shares of the company's pre-split common stock issued and outstanding will be automatically reclassified into 1 new share of its common stock. The stock split would reducethe number of shares outstanding from abo...
Iveda Solutions, Inc. (the “Company”) (NASDAQ: IVDA) announced that it has approved a 1-for-8 reverse stock split of the outstanding and authorized sh
The shareholders of the Company approved the share consolidation or reverse stock split, of the Company's ordinary shares, par value$0.001per share, at a ratio of one-for specific ratio to be determined by the Board of Directors (the "Board") in its sole discretion within the range of one...
Channel: Chinese Industry News Tags: Zircon Ore Summary: China Ceramics announces one-for-eight reverse stock split Ordinary shares will begin trading on NASDAQ stock market on a split-adjusted basis when market opens on June , Reverse stock split... ...
statements concerning the expected timing and implementation of the reverse stock split and the commencement of trading ofNuvve'spost-split common stock andNuvve'sability to maintain compliance with Nasdaq's continued listing requirements.Nuvvecautions you that these forward-looking statements are...
Cumulative Estimated Allocations fiscal year-to-date as ofJuly 31, 2024, for the fiscal year endingOctober 31, 2024: *Please note the figures shown above reflect the 2 to 1 reverse stock split which occurred onJune 21, 2024. Distributions paid prior toJune 21, 2024have been adjusted so tha...
ZyVersa Therapeutics, Inc. announces that its board of directors has approved a 1-for-35 reverse stock split of the Company’s common stock.